📰 Given Akumin News
Given Akumin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Given Akumin. Real-time updates on events, politics, business and more.
January 7, 2024
Akumin (NASDAQ:AKUMQ – Get Free Report) is one of 47 publicly-traded companies in the “Medical laboratories” industry, but how does it contrast to its peers? We will compare Akumin to related companies based on the strength of its valuation, earnings, profitability, dividends, institutional ownership, risk and analyst recommendations. Valuation & Earnings This table compares Akumin […]
January 5, 2024
Akumin (NASDAQ:AKUMQ – Get Free Report) is one of 47 public companies in the “Medical laboratories” industry, but how does it contrast to its competitors? We will compare Akumin to similar businesses based on the strength of its dividends, institutional ownership, risk, valuation, earnings, profitability and analyst recommendations. Volatility and Risk Akumin has a beta […]
December 25, 2023
Akumin (NASDAQ:AKUMQ – Get Free Report) is one of 42 public companies in the “Medical laboratories” industry, but how does it contrast to its rivals? We will compare Akumin to similar companies based on the strength of its risk, earnings, profitability, analyst recommendations, valuation, institutional ownership and dividends. Volatility and Risk Akumin has a beta […]
December 21, 2023
Akumin (NASDAQ:AKUMQ – Get Free Report) is one of 47 public companies in the “Medical laboratories” industry, but how does it contrast to its peers? We will compare Akumin to similar companies based on the strength of its earnings, profitability, analyst recommendations, risk, dividends, valuation and institutional ownership. Analyst Ratings This is a breakdown of […]
October 11, 2023
Aclarion (NASDAQ:ACON – Get Free Report) and Akumin (NASDAQ:AKU – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership. Earnings & Valuation This table compares Aclarion and Akumin’s […]
August 29, 2023
Akumin (NASDAQ:AKU – Get Free Report) and Veracyte (NASDAQ:VCYT – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, earnings, dividends and analyst recommendations. Profitability This table compares Akumin and Veracyte’s net margins, […]
July 6, 2023
Akumin (NASDAQ:AKU – Free Report) and Sonic Healthcare (OTCMKTS:SKHHY – Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability. Analyst Ratings This is a summary of current ratings and recommmendations […]
June 18, 2023
First Choice Healthcare Solutions (OTCMKTS:FCHS – Get Rating) and Akumin (NASDAQ:AKU – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability. Analyst Ratings This is a summary of recent ratings […]
May 23, 2023
Akumin (NASDAQ:AKU – Get Rating) and Fresh2 Group (NASDAQ:ANPC – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, risk, profitability and institutional ownership. Analyst Recommendations This is a summary of recent recommendations and […]
May 18, 2023
Akumin (NASDAQ:AKU – Get Rating) and Zicix (OTCMKTS:ZICX – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Institutional and Insider Ownership 25.8% of Akumin shares are owned by […]